Maria Touraki

Dr. Maria Touraki

Aristotle University, Thessaloníki, Kentrikí Makedonía, Greece
orcid
Assoc. professor

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
GKGloria Kyrila
Gloria Kyrila
AKAntonis Katsoulas
Antonis Katsoulas
VSVasiliki Schoretsaniti
Vasiliki Schoretsaniti
ARAngelos Rigopoulos
Angelos Rigopoulos
EREleftheria Rizou
Eleftheria Rizou
Maria TourakiMaria Touraki
Maria Touraki

9 April 2023 in Applied Sciences
Verified
Journal Article
Open access
PDF file
CTChristina Thoda
Christina Thoda
Maria TourakiMaria Touraki
Maria Touraki
Immune system modulation is an intriguing part of scientific research. It is well established that the immune system plays a crucial role in orchestrating cellular and molecular key mediators, thus establishing a powerful defense barrier against infectious pathogens. Gut microbiota represent a complex community of approximately a hundred trillion microorganisms that live in the mammalian gastrointestinal (GI) tract, contributing to the maintenance of gut homeostasis via regulation of the innate and adaptive immune responses. However, impairment in the crosstalk between intestinal immunity and gut microbiota may reflect on detrimental health issues. In this context, many studies have indicated that probiotics and their bioactive compounds, such as bacteriocins and short chain fatty acids (SCFAs), display distinct immunomodulatory properties through which they suppress inflammation and enhance the restoration of microbial diversity in pathological states. This review highlights the fundamental features of probiotics, bacteriocins, and SCFAs, which make them ideal therapeutic agents for the amelioration of inflammatory and autoimmune diseases. It also describes their underlying mechanisms on gut microbiota modulation and emphasizes how they influence the function of immune cells involved in regulating gut homeostasis. Finally, it discusses the future perspectives and challenges of their administration to individuals.

15 April 2012 in World Journal of Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
Maria TourakiMaria Touraki
Maria Touraki
GKGerda Karamanlidou
Gerda Karamanlidou
PKPenelope Karavida
Penelope Karavida
KCKaramanoli Chrysi
Karamanoli Chrysi

27 July 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
CTChristina Thoda
Christina Thoda
Maria TourakiMaria Touraki
Maria Touraki
Colorectal cancer (CRC) is a multifactorial disease with increased morbidity and mortality rates globally. Despite advanced chemotherapeutic approaches for the treatment of CRC, low survival rates due to the regular occurrence of drug resistance and deleterious side effects render the need for alternative anticancer agents imperative. Accumulating evidence supports that gut microbiota imbalance precedes the establishment of carcinogenesis, subsequently contributing to cancer progression and response to anticancer therapy. Manipulation of the gut microbiota composition via the administration of probiotic-derived bioactive compounds has gradually attained the interest of scientific communities as a novel therapeutic strategy for CRC. These compounds encompass miscellaneous metabolic secreted products of probiotics, including bacteriocins, short-chain fatty acids (SCFAs), lactate, exopolysaccharides (EPSs), biosurfactants, and bacterial peptides, with profound anti-inflammatory and antiproliferative properties. This review provides a classification of postbiotic types and a comprehensive summary of the current state of research on their biological role against CRC. It also describes how their intricate interaction with the gut microbiota regulates the proper function of the intestinal barrier, thus eliminating gut dysbiosis and CRC development. Finally, it discusses the future perspectives in precision-medicine approaches as well as the challenges of their synthesis and optimization of administration in clinical studies.

1 September 1989 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
PBPeter M. Brophy
Peter M. Brophy
APAthanasios Papadopoulos
Athanasios Papadopoulos
Maria TourakiMaria Touraki
Maria Touraki
BCBrian Coles
Brian Coles
WKWolfgang Körting
Wolfgang Körting
JBJohn Barrett
John Barrett

1 November 1995 in Aquaculture
Verified
Journal Article
Closed access
Maria TourakiMaria Touraki
Maria Touraki
PRPantelis Rigas
Pantelis Rigas
CKCostas Kastritsis
Costas Kastritsis